To provide timely, complementary evidence, we conducted a comparison of tirzepatide and semaglutide in patients at low, moderate and high cardiovascular risk who were diagnosed with obesity and type 2 diabetes and subgroups with specific cardiovascular conditions
If the question is, could this class of medicine keep you healthier for longer within your lifespan, the answer is the science is moving in that direction to support that. In cellular studies, we see reduced chronic inflammation, improved mitochondrial function [cell energy], better vascular function [blood flow], reduced oxidative stress, says Dr
Neuropsychiatric safety issues have become an area of interest given that many approved anti-obesity medications are centrally acting appetite suppressants [18, 19]
E., Sheehan, S
What Is the KLOW Peptide Stack